mRNA |
HLI 373 |
CTRPv2 |
pan-cancer |
AAC |
-0.017 |
0.6 |
mRNA |
istradefylline |
CTRPv2 |
pan-cancer |
AAC |
0.028 |
0.6 |
mRNA |
vincristine |
CTRPv2 |
pan-cancer |
AAC |
-0.015 |
0.7 |
mRNA |
BRD-K27188169:navitoclax (2:1 mol/mol) |
CTRPv2 |
pan-cancer |
AAC |
-0.024 |
0.7 |
mRNA |
MLN2238 |
CTRPv2 |
pan-cancer |
AAC |
0.017 |
0.7 |
mRNA |
tanespimycin:bortezomib (250:1 mol/mol) |
CTRPv2 |
pan-cancer |
AAC |
0.018 |
0.7 |
mRNA |
dabrafenib |
CTRPv2 |
pan-cancer |
AAC |
-0.023 |
0.7 |
mRNA |
FQI-1 |
CTRPv2 |
pan-cancer |
AAC |
-0.021 |
0.7 |
mRNA |
PDMP |
CTRPv2 |
pan-cancer |
AAC |
-0.018 |
0.7 |
mRNA |
tacedinaline |
CTRPv2 |
pan-cancer |
AAC |
-0.018 |
0.7 |